Lv1
52 积分 2025-10-15 加入
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)
1个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
1个月前
已完结
Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies
2个月前
已完结
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
2个月前
已完结
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
3个月前
已完结
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
4个月前
已完结
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
4个月前
已完结
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
4个月前
已完结
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
4个月前
已完结
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer
4个月前
已完结
皖公网安备34019202002308
